QOTD: Goldman Sachs Asks in Biotech Research Report – ‘Is Curing Patients a Sustainable Business Model?’ — RIELPOLITIK

Source – naturalnews.com – “…The success of its hepatitis C franchise has gradually exhausted the available pool of treatable patients,” the analyst wrote. “In the case of infectious diseases such as hepatitis C, curing existing patients also decreases the number of carriers able to transmit the virus to new patients, thus the incident pool also […]

via VOODOO ECONOMICS: Goldman Sachs Asks in Biotech Research Report – ‘Is Curing Patients a Sustainable Business Model?’ — RIELPOLITIK

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: